Ignite II

gmkb

Home
IGNITE
- ADOPT PGx
- GUARDD-US
IGNITE GDP
Publications
Affiliates
Training Opportunities
News & Events
- News
- Event Calendar

- GUARDD-US APOL1 Genetic Testing Manuscript Published March 6, 2026
  A new manuscript from the IGNITE Pragmatic Trials Network has been published in JAMA Network Open, describing the primary results of the GUARDD-US study. GUARDD-US is a randomized controlled trial examining the impact of returning APOL1 genetic risk results to ...
- ADOPT-PGx Acute Pain Manuscript Published with Invited Commentary February 20, 2026
  The ADOPT-PGx study examined the impact of genotype-guided opioid prescribing on postoperative pain management. Results from the study were recently published in JAMA Network Open, accompanied by an invited commentary reflecting on the findings and their implications for pharmacogenetics in ...

Search for:

GMKBignite toolbox Implementation Guides

Could a Community-Based Approach to Genetic Testing Help African Americans Reduce Risks of Chronic Kidney Disease?

Posted on March 25, 2022June 14, 2024 by Alexis

Mount Sinai, lead site for GUARDD-US, saw drops in blood pressure for hypertensive patients, supporting further trials and extensive community involvement

This entry was posted in GUARDD-US News, News. Bookmark the permalink.

← IGNITE celebrates Medical Genetics Awareness Week

Duke School of Medicine Genomic Seminar Series: Diana Bianchi, MD →

Home
IGNITE
- ADOPT PGx
- GUARDD-US
IGNITE GDP
Publications
Affiliates
Training Opportunities
News & Events
- News
- Event Calendar

IGNITE is an NIH-funded network dedicated to supporting the implementation of genomics in healthcare. Contact us to learn more about IGNITE and the work currently being conducted by the network

Contact IGNITE

Privacy Statement

WordPress is a content management system and should not be used to upload any PHI as it is not an environment for which we exercise oversight, meaning you the author are responsible for the content you post. Please use this system accordingly.